Zobrazeno 1 - 10
of 214
pro vyhledávání: '"Pär Stattin"'
Publikováno v:
European Urology. 82:e115
Publikováno v:
European Urology. 82:e113-e114
Autor:
Pär Stattin, Ola Bratt
Publikováno v:
European urology. 71(4)
Autor:
Glen Denmer Santok, Koon Ho Rha
Publikováno v:
European urology. 71(4)
Publikováno v:
BJU International. 131:486-493
Objective: To assess the strength of the evidence indicative of prostate cancer (PCa) progression as the adjudicated cause of death, according to age at death and PCa risk category. Patients and Methods: Using data from the Prostate Cancer data Base
Autor:
Casey Crump, Pär Stattin, James D. Brooks, Jan Sundquist, Anna Bill-Axelson, Alexis C. Edwards, Kristina Sundquist, Weiva Sieh
Publikováno v:
European Urology.
Publikováno v:
Journal of Urology. 209
Autor:
Oskar Bergengren, Christian Corsini, Stefan Carlsson, Ingela Franck-Lissbrant, Hans Garmo, Marie Hjelm-Eriksson, Per Fransson, Jon Kindblom, David Robinson, Marcus Westerberg, Pär Stattin, Sigrid Carlsson
Publikováno v:
Journal of Urology. 209
Autor:
Tiago M. Bonde, Marcus Westerberg, Markus Aly, Martin Eklund, Jan Adolfsson, Anna Bill-Axelson, Hans Garmo, Pär Stattin, David Robinson
Publikováno v:
Scandinavian Journal of Urology. 56:169-175
Objectives: To predict castration-resistant prostate cancer (CRPC) and prostate cancer (Pca) death by use of clinical variables at Pca diagnosis and PSA levels after start of gonadotropin-releasing hormone agonists (GnRH) in men with non-metastatic c
Autor:
Charlotte Alverbratt, Hanna Vikman, Marie Hjälm Eriksson, Pär Stattin, Ingela Franck Lissbrant
Publikováno v:
Scandinavian Journal of Urology. 56:95-101
Background Patients with advanced prostate cancer (PCa) typically undergo numerous lines of treatment leading to large amounts of information in Electronic Health Records (EHRs). The Patient-overview Prostate Cancer (PPC) presents clinical informatio